FDA approves Tanzeum (albiglutide), a new type 2 diabetes drug

Tanzeum “can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of diabetes,” Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II in the FDA’s Center for Drug Evaluation and Research, said in an agency news release Read more



from DiabetesNews http://ift.tt/1qHw0FB